| abstract |
The present invention relates to a new agomelatine composition, particularly agomelatine in solution which isadsorbed on an inert carrier or directly formulated. Another subject-matter of the invention is a solid form made of an agomelatine in solution adsorbate and a process for the preparation of said solid form as well as the use of the adsorbate and of the composition in therapy, and pharmaceutical compositions comprising the same. |